Table 5.
Percentage of HPV positive infants at different points during follow-up according to mother's HPV status and specific genotypes detected in mother/child HPV positive pairs.
| Infants' HPV positivity by follow-up period | ||||
|---|---|---|---|---|
| Mothers' HPV status | at 0 to 6 days | at 6 weeks | at 3 to 24 months |
Any time (0 to 24 months) |
| % (HPV+/tested) | % (HPV+/tested) | % (HPV+/tested) | % (HPV+/tested) | |
| At pregnancy | ||||
| HPV negative | 3.1% (2/64) | 11.9% (7/59) | 7.4% (4/54) | 16.9% (13/77) |
| HPV positive | 9.4% (5/53) | 13.7% (7/51) | 11.8% (4/34) | 19.7% (13/66) |
| Mother/child HPV positive pairs with concordant genotypes [types in mother/child pairs] |
1 of 5 [16,6,11/6,11] |
2 of 7 [16/16; 18/18] |
2 of 4 [16/16; 18/18] |
4 of 13 [16,6,11/6,11; 16/16; 16/16; 18/18] |
| Mother/child HPV positive pairs with discordant genotypes [types in mother/child pairs] |
4 of 5 [18/6,11; X/X; X/X; X/31] |
5 of 7 [18/6,11; 18/6,11; X/X; X/X; 16/X] |
2 of 4 [6,11/16; X/X] |
9 of 13 [18/6,11; 18/6,11; 6,11/16; X/31; X/X; X/X; X/X; X/X; X/X] |
| Fisher's exact test* | 0.2 | 0.8 | 0.7 | 0.7 |
| At 6 weeks postpartum | ||||
| HPV negative | 2.7% (2/74) | 7.2% (6/83) | 6.2% (4/65) | 12.9% (12/93) |
| HPV positive | 11.1% (2/18) | 27.3% (6/22) | 21.4% (3/14) | 32.0% (8/25) |
| Mother/child HPV positive pairs with concordant genotypes [types in mother/child pairs] |
0 of 2 | 2 of 6 [18,6,11/6,11; 18/18] |
2 of 3 [18/18; 16,6,11/16] |
3 of 8 [18,6,11/6,11; 18/18; 16,6,11/16] |
| Mother/child HPV positive pairs with discordant genotypes [types in mother/child pairs] |
2 of 2 [16/X; 18/6,11] |
4 of 6 [18/6,11; X/X; 16,6,11/X; X/6,11] |
1 of 3 [6,11/16] |
5 of 8 [18/6,11; 6,11/16; X/X; 16/X; X/6,11] |
| Fisher's exact test* | 0.2 | 0.02 | 0.1 | 0.03 |
* For the association between HPV status in mother and HPV status in child